Dhaval Mehta

Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia

Kenneth A. Foon, Dhaval Mehta, Suzanne Lentzsch et al. · Blood · 2012 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the neoadjuvant pathologic complete response (pCR) rate (ECOG-ACRIN EA2174).

Jennifer R. Eads, Noah Graham, Michael K. Gibson et al. · Journal of Clinical Oncology · 2024 · 21 citations

Medicine, Oncology, Pharmacology +17

Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy

Dhaval Mehta, Kenneth A. Foon, Robert L. Redner et al. · Leukemia Research · 2011 · 14 citations

Medicine, Oncology, Pharmacology +15